Tempus AI (NASDAQ:TEM) COO Ryan Fukushima Sells 5,000 Shares of Stock

Tempus AI, Inc. (NASDAQ:TEM) COO Ryan Fukushima sold 5,000 shares of the company’s stock in a transaction on Monday, January 5th. The shares were sold at an average price of $64.26, for a total transaction of $321,300.00. Following the completion of the transaction, the chief operating officer owned 148,808 shares of the company’s stock, valued at approximately $9,562,402.08. The trade was a 3.25% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Ryan Fukushima also recently made the following trade(s):

• On Monday, December 1st, Ryan Fukushima sold 5,000 shares of Tempus AI stock. The shares were sold at an average price of $75.72, for a total transaction of $378,600.00.
• On Tuesday, November 18th, Ryan Fukushima sold 10,099 shares of Tempus AI stock. The shares were sold at an average price of $65.54, for a total transaction of $661,888.46.
• On Monday, November 3rd, Ryan Fukushima sold 5,000 shares of Tempus AI stock. The stock was sold at an average price of $89.03, for a total value of $445,150.00.

Tempus AI Stock Up 0.3%

Tempus AI stock opened at $69.77 on Thursday. The company has a market capitalization of $12.41 billion, a P/E ratio of -58.63 and a beta of 5.22. The company has a debt-to-equity ratio of 2.45, a quick ratio of 3.12 and a current ratio of 3.28. Tempus AI, Inc. has a fifty-two week low of $31.36 and a fifty-two week high of $104.32. The stock has a 50-day simple moving average of $71.08 and a 200-day simple moving average of $73.35.

Tempus AI (NASDAQ:TEM) last released its quarterly earnings results on Tuesday, November 4th. The company reported ($0.11) EPS for the quarter, topping the consensus estimate of ($0.16) by $0.05. The company had revenue of $334.21 million for the quarter, compared to analyst estimates of $328.89 million. Tempus AI had a negative return on equity of 73.21% and a negative net margin of 18.45%.The firm’s revenue was up 84.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.46) earnings per share. Equities research analysts expect that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of TEM. Cranbrook Wealth Management LLC purchased a new stake in shares of Tempus AI during the 3rd quarter worth $25,000. Concord Wealth Partners lifted its stake in shares of Tempus AI by 308.0% in the second quarter. Concord Wealth Partners now owns 408 shares of the company’s stock valued at $26,000 after purchasing an additional 308 shares during the period. JPL Wealth Management LLC purchased a new stake in Tempus AI during the third quarter worth about $26,000. GAMMA Investing LLC acquired a new position in Tempus AI during the third quarter worth about $28,000. Finally, Allworth Financial LP grew its position in Tempus AI by 5,000.0% during the second quarter. Allworth Financial LP now owns 459 shares of the company’s stock worth $29,000 after buying an additional 450 shares during the period. Institutional investors and hedge funds own 24.22% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the stock. JPMorgan Chase & Co. lowered their price objective on shares of Tempus AI from $85.00 to $80.00 and set a “neutral” rating on the stock in a research report on Monday, December 15th. Guggenheim boosted their price target on Tempus AI from $80.00 to $95.00 and gave the company a “buy” rating in a research report on Friday, September 26th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Tempus AI in a research note on Wednesday, October 8th. Piper Sandler decreased their price objective on Tempus AI from $105.00 to $80.00 and set a “neutral” rating for the company in a research report on Tuesday, November 11th. Finally, TD Cowen lowered Tempus AI from a “buy” rating to a “hold” rating and set a $88.00 target price on the stock. in a report on Tuesday, October 21st. Seven investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Tempus AI has an average rating of “Hold” and a consensus price target of $84.00.

Tempus AI Company Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.